The global seroprevalence of Toxoplasma gondii infection in workers occupationally exposed to animals (1972-2023): a systematic review and meta-analysis.
Abdullah A A MohammedMusa AhmedNasir A IbrahimPublished in: The veterinary quarterly (2024)
Toxoplasma gondii , a ubiquitous zoonotic parasite infecting warm-blooded animals, poses a significant health threat to workers with occupational animal exposure (WOEA) due to their frequent contact with potential reservoirs. Existing data on T. gondii seroprevalence in the WOEA exhibits substantial global variation. This systematic review and meta-analysis, adhering to PRISMA guidelines, aimed to quantify the global seroprevalence of T. gondii infection among WOEA over the past five decades (1972-2023). We identified 66 eligible studies through a comprehensive search strategy encompassing English publications, with a total sample size of 15,279. A random-effects model with the Freeman-Tukey transformation in STATA v16.0 accounted for the high heterogeneity observed. We estimated the pooled global seroprevalence of T. gondii infection in WOEA at 41% (95% CI: 36-47%). Subgroup analyses revealed significant variations by gender: males (63%) vs. females (37%) ( p < 0.05), occupation: non-livestock workers (54%), livestock workers (47%), slaughterhouse workers (44%), and veterinary personnel (27%) ( p < 0.05). Geographic trends showed the highest prevalence in Africa (51%), followed by South America (49%), Europe (47%), Australia (43%), Asia (36%), and North America (23%; p < 0.05). Lower prevalence was observed in high-income (39%) and upper-middle-income (38%) countries compared to lower-middle-income (44%) and low-income (48%) countries ( p < 0.05). This analysis underscores the high global seroprevalence of T. gondii in the WOEA, highlighting the need for targeted interventions in this high-risk population.
Keyphrases
- toxoplasma gondii
- mental health
- physical activity
- healthcare
- risk factors
- public health
- clinical trial
- single cell
- machine learning
- electronic health record
- clinical practice
- randomized controlled trial
- health information
- open label
- deep learning
- cancer therapy
- artificial intelligence
- drug delivery
- risk assessment
- case control
- meta analyses